Patents by Inventor Isabel Delgado

Isabel Delgado has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12246006
    Abstract: It relates to a single-dose packaging unit which is a blow-fill-seal (BFS) container which comprises a sterile pharmaceutical or veterinary liquid composition which is a solution, wherein a) the composition comprises a therapeutically effective amount of clotrimazole or a pharmaceutically or veterinary acceptable salt thereof, together with one or more pharmaceutically or veterinary acceptable excipients or carriers, and b) the container has a volume from 0.05 to 8 mL, with the condition that the water content of the composition is equal to or lower than 4% by weight with respect to the total composition weight. It also relates to a secondary packaging comprising one or more single-dose packaging units.
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: March 11, 2025
    Assignee: LABORATORIOS SALVAT, S.A.
    Inventors: Maria Mar Terraz Mendoza, Javier Sanagustín Aquilué, Adolfo Téllez Molina, María Isabel Delgado Gañán
  • Patent number: 11672798
    Abstract: The present invention provides a combination comprising ciprofloxacin, or a pharmaceutically acceptable salt thereof, and fluocinolone acetonide for use in the prevention and/or treatment of an ocular disease, wherein the prevention and/or treatment comprises the topical administration of the combination. The invention also provides an ophthalmic topical pharmaceutical composition comprising the combination together with at least one ophthalmically acceptable excipient, diluent, or carrier, for use in the prevention and/or treatment of an ocular disease, wherein the prevention and/or treatment comprises the topical administration of the composition.
    Type: Grant
    Filed: December 23, 2021
    Date of Patent: June 13, 2023
    Assignee: LABORATORIOS SALVAT, S.A.
    Inventors: Sandra Marchán Sancho, Francisca Toribio Santisteban, María Isabel Delgado Gañán
  • Publication number: 20220387422
    Abstract: The present invention provides a combination comprising ciprofloxacin, or a pharmaceutically acceptable salt thereof, and fluocinolone acetonide for use in the prevention and/or treatment of an ocular disease, wherein the prevention and/or treatment comprises the topical administration of the combination. The invention also provides an ophthalmic topical pharmaceutical composition comprising the combination together with at least one ophthalmically acceptable excipient, diluent, or carrier, for use in the prevention and/or treatment of an ocular disease, wherein the prevention and/or treatment comprises the topical administration of the composition.
    Type: Application
    Filed: December 23, 2021
    Publication date: December 8, 2022
    Inventors: Sandra MARCHÁN SANCHO, Francisca Toribio Santisteban, MarÍa Isabel DELGADO GAÑÁN
  • Publication number: 20220133695
    Abstract: It relates to a single-dose packaging unit which is a blow-fill-seal (BFS) container which comprises a sterile pharmaceutical or veterinary liquid composition which is a solution, wherein a) the composition comprises a therapeutically effective amount of clotrimazole or a pharmaceutically or veterinary acceptable salt thereof, together with one or more pharmaceutically or veterinary acceptable excipients or carriers, and b) the container has a volume from 0.05 to 8 mL, with the condition that the water content of the composition is equal to or lower than 4% by weight with respect to the total composition weight. It also relates to a secondary packaging comprising one or more single-dose packaging units.
    Type: Application
    Filed: February 18, 2020
    Publication date: May 5, 2022
    Inventors: Maria Mar TERRAZ MENDOZA, Javier SANAGUSTÍN AQUILUÉ, Adolfo TÉLLEZ MOLINA, María Isabel DELGADO GAÑÁN
  • Publication number: 20200390729
    Abstract: The invention relates to a new therapeutic approach for treatment and/or prevention of a disease of the posterior segment of the eye, in particular for retinal and optic nerve pathologies. Dobesilic acid and/or a pharmaceutically acceptable salt, or an ester of any of the acid or the salt, are proposed for use topically administered onto eye surface. There are also disclosed new compositions comprising dobesilic acid and/or a pharmaceutically acceptable salt, or an ester of any of the acid or the salt, adapted for performing the treatment and/or prevention of diseases of the posterior segment of the eye.
    Type: Application
    Filed: November 29, 2018
    Publication date: December 17, 2020
    Inventors: Xavier CAPDEVILA NORTES, Javier SANAGUSTIN AQUILUE, Maria Isabel DELGADO GANAN
  • Patent number: 10857160
    Abstract: It relates to an oil-in-water nanoemulsion composition having a continuous aqueous phase and dispersed oil droplets, wherein the nanoemulsion comprises: (a) clobetasol; (b) one or more oil components; and (c) one or more surfactants; together with one or more pharmaceutically acceptable excipients or carriers wherein: the osmolality of the nanoemulsion is comprised from 100 mOsm/Kg to 500 mOsm/Kg; the droplet average size measured by Dynamic light scattering is comprised from 1 nm to 500 nm; the weight ratio between the oil components and the sum of the oil components and one or more surfactants is comprised from 0.001 to 0.5; the weight ratio between the oil component and clobetasol is comprised from 1:1 to 200:1; and the weight ratio between the surfactant and clobetasol is comprised from 2:1 to 200:1. It also relates to processes for its preparation, its use as a medicament, and in the prophylaxis and/or treatment of inflammatory diseases or conditions.
    Type: Grant
    Filed: January 18, 2018
    Date of Patent: December 8, 2020
    Assignee: LABORATORIOS SALVAT, S.A.
    Inventors: Javier Sanagustin Aquilue, María Del Carmen Lendínez Gris, Maria Isabel Delgado Gañán
  • Patent number: 10660848
    Abstract: The present invention relates to a sterile ophthalmic composition comprising castor oil and a medium chain triglyceride, to its use in medicine, in particular for the treatment and/or prevention of an ocular disease selected from the group consisting of dry eye, conjunctivitis, dermatitis, blepharitis, entropion, floppy eyelid syndrome, thyroid ophthalmopathy, pterygium, conjunctivochalasis, epithelial damage induced by preservatives, epithelial or anterior chamber damage induced by ocular surgery, limbal cell deficiency, corneal ulcers induced by physical or chemical agents, keratitis, episcleritis and uveitis.
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: May 26, 2020
    Assignee: LABORATORIOS SALVAT, S.A.
    Inventors: Francisca Izquierdo Torres, Sandra Marchan Sancho, Isabel Delgado Gañán
  • Publication number: 20190298737
    Abstract: It relates to an oil-in-water nanoemulsion composition having a continuous aqueous phase and dispersed oil droplets, wherein the nanoemulsion comprises: (a) clobetasol; (b) one or more oil components; and (c) one or more surfactants; together with one or more pharmaceutically acceptable excipients or carriers wherein: the osmolality of the nanoemulsion is comprised from 100 mOsm/Kg to 500 mOsm/Kg; the droplet average size measured by Dynamic light scattering is comprised from 1 nm to 500 nm; the weight ratio between the oil components and the sum of the oil components and one or more surfactants is comprised from 0.001 to 0.5; the weight ratio between the oil component and clobetasol is comprised from 1:1 to 200:1; and the weight ratio between the surfactant and clobetasol is comprised from 2:1 to 200:1. It also relates to processes for its preparation, its use as a medicament, and in the prophylaxis and/or treatment of inflammatory diseases or conditions.
    Type: Application
    Filed: January 18, 2018
    Publication date: October 3, 2019
    Applicant: Laboratorios Salvat, S.A.
    Inventors: Javier SANAGUSTIN AQUILUE, María Del Carmen LENDÍNEZ GRIS, Maria Isabel DELGADO GAÑÁN
  • Publication number: 20180008538
    Abstract: The present invention relates to a sterile ophthalmic composition comprising castor oil and a medium chain triglyceride, to its use in medicine, in particular for the treatment and/or prevention of an ocular disease selected from the group consisting of dry eye, conjunctivitis, dermatitis, blepharitis, entropion, floppy eyelid syndrome, thyroid ophthalmopathy, pterygium, conjunctivochalasis, epithelial damage induced by preservatives, epithelial or anterior chamber damage induced by ocular surgery, limbal cell deficiency, corneal ulcers induced by physical or chemical agents, keratitis, episcleritis and uveitis.
    Type: Application
    Filed: July 7, 2017
    Publication date: January 11, 2018
    Inventors: Francisca Izquierdo Torres, Sandra Marchan Sancho, Isabel Delgado Gañán
  • Publication number: 20160331563
    Abstract: A prosthetic device adapted to be worn on a lower limb of a patient is provided. The prosthetic device includes a socket having an inner surface of which contacts the limb of the patient when the prosthetic device is worn by the patient. Pressure sensors are provided on the inner surface of the socket which measure pressure at the socket-limb interface when the prosthetic device is worn by the patient. The prosthetic device also includes a processor and a wireless transceiver. The processor receives data from the pressure sensors and wirelessly transmits the data to a remote wireless device. A system including the prosthetic device and a remote wireless device is also provided. The remote wireless device can display a map of pressure as a function of sensor location at the socket-limb interface and issue a warning to the patient if the pressure at a sensor location exceeds a specified value. Methods of using the prosthetic to monitor pressure at the socket-limb interface are also provided.
    Type: Application
    Filed: May 16, 2016
    Publication date: November 17, 2016
    Inventors: Justin M. KANE, Mariah Anne CODY, Kayla Marie DELANEY, Laura Isabel Delgado GARCIA, Istvan MORITZ, Darren Kailung JENG
  • Publication number: 20130237579
    Abstract: The present invention relates to stable pharmaceutical compositions comprising one or more HMG-CoA reductase inhibitors, processes for preparing the stable compositions and uses for the compositions. The stable pharmaceutical compositions of the invention may be used, in particular, for the treatment of hyperlipoproteinemia and atherosclerosis.
    Type: Application
    Filed: July 11, 2008
    Publication date: September 12, 2013
    Inventors: Timothy Stanley, Isabel Delgado, Estela Llorens, Eva Munoz
  • Publication number: 20130136795
    Abstract: The present invention relates to stable solid pharmaceutical compositions comprising valsartan as the active pharmaceutical ingredient. Optionally the compositions comprise one or more further active pharmaceutical ingredients. The invention further relates to methods for preparing said compositions and to the use of said compositions in the treatment or prevention of angiotensin receptor mediated disorders, in particular hypertension and related disorders.
    Type: Application
    Filed: August 8, 2008
    Publication date: May 30, 2013
    Applicants: Poligono Merck, Generics [UK] Limited
    Inventors: Miguel Barrero, Isabel Delgado